Shortly after announcing a delay in the merger to the second half of this year, Mylan has offered concessions to the European Commission’s department for competition to address antitrust concerns about its plans to join with Pfizer’s Upjohn mature brands and off-patent division.
A provisional deadline of 22 April has been set by the Commission for its decision, after Mylan put forward its concessions on 27 March